Composition for prophylaxis or treatment of cerebral infarction

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/12 (2006.01) A61K 38/08 (2006.01) A61K 38/22 (2006.01)

Patent

CA 2209006

A pharmaceutical composition comprising a compound having anti-endothelin activity is useful for the prophylaxis or treatment of cerebral infarction. The compound having anti-endothelin activity is a cyclic hexapeptide of the formula: (see fig. I) (in which X and Y are a D-, L- or DL-.alpha.-amino acid residue; A is a D-acidic .alpha.-amino acid residue; B is a D- or L-neutral .alpha.-amino acid residue; C is an L-.alpha.-amino acid residue; E is a D-.alpha.-amino acid residue having an aromatic ring).

Une composition pharmaceutique contenant un composé ayant une activité anti-endothéline utilisable à des fins prophylactiques ou pour le traitement de l'infarctus cérébral. Le composé ayant l'activité anti-endothéline est un hexapeptide cyclique de formule : (voir la fig. I) (où X et Y représentent un résidu de D-, de L- ou de DL-alpha-aminoacide; A, un résidu acide de D-alpha-aminoacide; B, un résidu neutre de D- ou de L-alpha-aminoacide; C, un résidu de L-alpha-aminoacide; E, un résidu de D-alpha-aminoacide porteur d'un noyau aromatique).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Composition for prophylaxis or treatment of cerebral infarction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for prophylaxis or treatment of cerebral infarction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for prophylaxis or treatment of cerebral infarction will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1570929

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.